Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 16/10/2019
SIETES contiene 92824 citas

 
 
 1 a 20 de 35 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Archibald K, Coleman R, Foster C, on behalf of 19 other signatories. Open letter to UK Prime Minister David Cameron and Health Secretary Andrew Lansley on safety of medicines. Lancet 2011;377:1915. [Ref.ID 91289]
2.Tiene citas relacionadas Cita con resumen
Perel P, Roberts I, Sena E, Wheble P, Briscoe C, Sandercock P, Macleod M, Mignini LE, Jayaram P, Khan KS. Comparison of treatment effects between animal experiments and clinical trials: systematic review. BMJ 2007;334:197-200. [Ref.ID 79011]
3.Tiene citas relacionadas Cita con resumen
Watts G. Animal testing: is it worth it?. BMJ 2007;334:182-4. [Ref.ID 79008]
4.Tiene citas relacionadas Cita con resumen
Hackam DG. Translating animal research into clinical benefit. BMJ 2007;334:163-4. [Ref.ID 79001]
5. Cita con resumen
Crowley Jr WF. Drug development and clinical research in the UK. Lancet 2007;369:174-5. [Ref.ID 78901]
6.Tiene citas relacionadas Cita con resumen
Focosi D. Risk in drug trials. Lancet 2007;368:2206. [Ref.ID 78718]
7.Tiene citas relacionadas Cita con resumen
Ohresser M, Olive D, Vanhove B, Watier H. Risk in drug trials. Lancet 2007;368:2205-006. [Ref.ID 78717]
8.Tiene citas relacionadas Cita con resumen
Barnes MR, Holbrook J, Feild JA, Searls DB, Sanseau P. Risk in drug trials. Lancet 2007;368:2205. [Ref.ID 78716]
9.Tiene citas relacionadas Cita con resumen
Kane A. Was Tegenero antibody dose too high?. Scrip 2006;3161/62:30-1. [Ref.ID 77122]
11. Cita con resumen
Anónimo. SuperMAB on trial. Lancet 2006;367:960. [Ref.ID 76447]
12.Tiene citas relacionadas Cita con resumen
Pound P, Ebrahim S, Sandercock P, Bracken MB, Roberts I, on behalf of the Reviewing Animal Trials Systematically (RATS) Group. Where is the evidence that animal research benefits human?. BMJ 2004;328:514-7. [Ref.ID 69248]
13.
Davila JC, Rodriguez R J, Melchert RB, Acosta D. Predictive value of in vitro model systems in toxicology. Annu Rev Pharmacol Toxicol 1998;38:63-96. [Ref.ID 44167]
15. Cita con resumen
Lasagna L. The diseases drugs cause. Perspect Biol Med 1964;714:457-70. [Ref.ID 35048]
16.
Choudary J, Contrera JF, DeFelice A, DeGeorge JJ, Farrelly JG, Fitzgerald G, Goheer MA, Jacobs A, Jordan A, Meyers L, Ostergerg R, Resnick Ch, Sun J, Temple RJ. Response to Monro and Mehta proposal for use of single-dose toxicology studies to support single-dose studies of new drugs in humans. Clin Pharmacol Ther 1996;59:265-7. [Ref.ID 28003]
17.
Monro A, Mehta D. Are single-dose toxicology studies in animals adequate to support single doses of a new drug in humans?. Clin Pharmacol Ther 1996;59:258-64. [Ref.ID 28002]
18.
Contrera JF, Aub D, Barbehenn E, Belair E, Chen C, Evoniuk G, Mainigi K, Mielach F, Sancilio L. A retrospective comparison of the results of 6 and 12 month non-rodent toxicity studies. Adverse Drug React Toxicol Rev 1993;12:63-76. [Ref.ID 19353]
20.
Hickey JP, Aldridge AJ, Passino-Reader D R, Frank AM. An expert system for prediction of chemical toxicity. Drug Inf J 1992;26:487-95. [Ref.ID 18385]
Seleccionar todas
 
 1 a 20 de 35 siguiente >>